Serdar Arici
Istanbul, 34947, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Body Mass Index Does Not Predict High Miller-Payne Response to Neoadjuvant Chemotherapy in Stage II-III Breast Cancer: A Single-Center Retrospective Cohort Study of 647 Patients.
Journal: Journal of clinical medicine
Published: March 16, 2026
Prior curative-intent treatment strategy affects progression outcomes of first-line immunotherapy in metastatic non-small cell lung cancer: A retrospective cohort study.
Journal: Experimental and therapeutic medicine
Published: January 06, 2026
Prognostic significance of HER2 loss after HER2-targeted neoadjuvant treatment in patients with HER2-positive locally advanced breast cancer.
Journal: Current problems in cancer
Published: June 30, 2023
How reliable is the high-volume definition in prostate cancer patients: the potential game-changing role of PSMA.
Journal: Nuclear medicine communications
Published: June 19, 2023
The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer.
Journal: Breast care (Basel, Switzerland)
Published: May 15, 2022
Can 68Ga-PSMA PET/CT-derived prostate-specific membrane antigen expression parameters predict prostate-specific antigen response to enzalutamide treatment?
Journal: Nuclear medicine communications
Published: May 07, 2021
The effect of body mass index on location of recurrence and survival in early-stage colorectal cancer.
Journal: Journal of cancer research and therapeutics
Published: December 31, 2020
Perioperative 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in gastric cancer: Pathological regression grade and its relationship to clinical outcome.
Journal: Indian journal of cancer
Published: November 29, 2020
Assessment of pretreatment albumin-bilirubin grade in pancreatic cancer patients with liver metastasis.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: October 25, 2020
The conversion of RAS status in metastatic colorectal cancer patients after first-line biological agent treatment.
Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
Published: June 29, 2020
Does the Waiting Period for Genetic Tests Affect the Prognosis in Chemotherapy-Treated de novo Metastatic Non-Small Cell Lung Cancer Patients without a Driver Mutation?
Journal: Oncology research and treatment
Published: May 01, 2020
Last Updated: 09/26/2026